x

Join Advarra

Learn more about our company team, careers, and values. Join Advarra’s Talented team to take on engaging work in a dynamic environment.

See Jobs

Speed, Not Silos

Clinical trials need technology and services that bring people together. Advarra accelerates trial outcomes by uniting patients, sites, sponsors and CROs in a single, connected ecosystem.

Reimagine Clinical Research

Connect Stakeholders
Bring everyone together and keep them connected to the information they need to accelerate clinical trial outcomes. Learn More >

Protect Trial Participants
We’ve been patient-centric since the beginning, and our research review services are unmatched in the category. Learn More >

Deliver Innovation
We don’t rest in our mission to make clinical research safer, smarter, and faster for patients, sites, sponsors and CROs. Learn More >

Proven Clinical Research Services and Technology

#1 in Trusted Research
Review Services

Learn More >

#1 in Connected Site and
Sponsor Technology

Learn More >

Reimagining the Clinical
Research Experience

Learn More >

Top Clinical Research Sponsors, CROs, and Sites Partner with Advarra to Accelerate Their Clinical Research

3,500+

institutions, hospitals, health systems, and academic medical centers trust Advarra.

50K

investigators utilize Advarra trial technology solutions to support their research.

12K+

open protocols overseen by Advarra annually

78%

of NCI-designated Cancer Centers use Advarra technology.

Bring Your Clinical Trial Together

Advarra’s IRB and IBC reviews and Gene Therapy Ready site network helped reduce study startup timelines and delivered trial results to IQVIA quicker than expected.

At Inova Health System, the research team improved regulatory efficiency by 20% without the need for extra regulatory staff by adopting Advarra’s eRegulatory Management System.

Using Advarra Insights, The University of Wisconsin Carbone Cancer Center was able to enhance their data analytics and visualization capabilities.

Advarra served as the institutional review board (IRB) of record for the phase I trial for the first-in-human dose-escalation study of an mRNA Vaccine Against SARS-CoV-2.

Longboat:
The Reimagined
Clinical Trial Experience

Longboat is the single hub to centralize, connect, and simplify your clinical trials

Create a central hub for a study to reduce burden and increase visibility

Modern, simple technology that sites want to use

Faster startup and improved regulatory process efficiency

The 2023 Study
Activation Report

Hear from clinical researchers striving to get life-saving therapies into the market.

Read about

  • How a proliferation of technology and process is creating delays and adding administrative burdens that stall clinical research progress.
  • What sponsors and CROs are doing to reduce site feasibility burdens.
  • Which technology improvements are impacting study activation strategies.

Are You Ready to Bring People Together for Better, Faster Trial Outcomes?